) than Hispanic children; this was sig-P p .01 nificantly driven by robust responses in African American girls near the age of puberty, many of whom carried the human leukocyte antigen class I B*58 allele.
pared with whites infected with HIV-1, blacks have a slower decline in CD4 + cell counts [4, 5] . However, one study showed no racial differences in CD4 + cell counts or viral load when all races were socioeconomically equal and had a similar quality of health care [6] . Therefore, the basis for observed differences in HIV disease progression is unclear, although it leaves open the question of whether there are differences in immune response to HIV-1 based on race or ethnicity.
There is evidence for immunological differences between races in other diseases. African Americans show a higher incidence and morbidity rate of systemic lupus erythematosus [7] [8] [9] and of transplant rejection [10, 11] than do other ethnic groups. It has been proposed that these observations can be explained by a more robust T cell response in African Americans than in other ethnic groups that is perhaps due to enhanced costimulation [12] or to cytokine polymorphisms [13] . African Americans with hepatitis C virus (HCV) infection more often develop chronicity and liver cancer than do whites, and they demonstrate lower responsiveness to interferon (IFN)-a therapy, although they tend to have a more benign outcome. These differences are thought to be the result of an increased and broader HCV CD4 + cell response in African Americans than in whites [14, 15] .
There is not much known about the immune response and its relationship to viral load and disease progression in children vertically infected with HIV-1. The dynamics of HIV-1 infection are markedly different in children from those in adults. Neonates have a higher initial viral burst, and viral loads decrease slowly over a period of years [16, 17] , whereas adults generally control the initial viral burst within 3-4 months [18, 19] . The higher viral burst in neonates is thought to be a result of higher thymic output and high numbers of circulating CD4 + cells, which serve as targets for HIV-1 [20] . The strength and breadth of the HIV-specific CD8 + cell response in perinatally infected children has been shown to be influenced by the state of the CD4 + cell compartment, as well as by age [21] . To date, few studies have investigated differences in the HIVspecific immune response between ethnic and sex groups. In the present study, we compared the magnitude and breadth of HIV-1-specific T cell immune responses in HIV-1-infected Hispanic and African American children matched by sex, age, viral load, and CD4 + cell count or percentage.
SUBJECTS, MATERIALS, AND METHODS
Subject samples and matching. The subjects, all of whom were perinatally infected, were attendees of the Pediatric HIV clinic at Jacobi Medical Center, Bronx, NY. The preexisting samples were chosen for the study on the basis of ease of matching characteristics with other subject samples. Heparinized whole blood samples were obtained from 41 children after they or their guardians provided informed consent, in accordance with local institutional review board-approved protocols.
Patients were classified as Hispanic or African American by clinician determination. Plasma HIV-1 RNA loads were measured with the Amplicor HIV-1 Monitor (Roche Diagnostic Systems), which has a lower limit of quantification of 50 copies RNA/mL. One Hispanic child was matched with 1 African American child on the basis of proximity of age, viral load, and either CD4 + cell count or percentage. In all but 2 pairs, sex was matched as well.
Children were first matched as closely as possible by plasma HIV-1 RNA load, to within 0.3 log 10 HIV-1 RNA copies/ mL. They were then matched for age at the time of study and categorized into 1 of 3 age groups: !4 years (48 months; n p 6), 4-9 years (49-97 months;
), and 10-18 years (98-n p 9 209 months;
). Patients !48 months old were matched n p 24 to within 6 months, because the CD4 + cell compartment is very dynamic during the first 2 years of life [21] . As children mature, their immune system more closely resembles that of adults.
With this consideration, patients 4-9 years old were matched to within 18 months, and those 110 years old were matched to within 24 months.
The CD4 + cell count is also known to influence the magnitude of a cell-mediated immune response in children [21] . Hence, samples were matched as closely as possible for CD4 + cell count or percentage. There were a few pairs for whom viral load and age were closely matched but CD4 + cell characteristics were not. There was no appreciable difference in CD4 + cell counts between African American and Hispanic children as a whole.
Five samples (3 from Hispanic and 2 from African American children) were not included in the analysis because of an inadequate number of cells or a failure to respond to the positive control. The resulting unpaired samples were included in the data analysis, because they did not differ from the balance of the cohort with respect to viral load, age, and CD4 + cell count. Detection of HIV-specific T cell responses. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque PLUS density-gradient centrifugation (Amersham Pharmacia Biotech) and then cryopreserved. Quantification of HIV-specific T cell responses by thawed, viable PBMCs was performed by use of the cytokine-amplified enzyme-linked immunospot (ELISPOT) assay [22] . Briefly, each well of a 96-well plate (MAHAS4510; Millipore) was coated with 50 mL of anti-IFN-g monoclonal antibody (MAb; Mabtech) at a concentration of 5 mg/mL. After incubation, each well was washed and blocked with 15% fetal calf serum in RPMI 1640 (Cellgro). PBMCs ( Ϫ ) 5 5 1 ϫ 10 2 ϫ 10 were added to duplicate wells, and synthetic peptides (15-mers) of the clade B consensus sequences of Gag (Becton Dickinson), Nef, or Tat (AIDS Research and Reference Reagent Program, National Institutes of Health) were added at a concentration of 1 mg/mL to the wells with interleukin (IL)-7 and IL-15 at a concentration of 2.5 ng/mL (R&D Systems). Staphylococcus enterotoxin B was used as a positive control, and medium alone, with IL-7 and IL-15, was used as a negative control. After incubation at 37ЊC, plates were washed. Biotinylated anti-IFN-g MAb 7-B6-1 (Mabtech) was added at a concentration of 1 mg/ mL and incubated at 37Њ C. Plates were washed and treated with avidin-conjugated horseradish peroxidase-H (Vector Laboratories). After 1 h, plates were washed. Fifty microliters of stable diaminobenzidene tetrahydrochloride substrate (Research Genetics) was added, and plates were washed. IFN-g spot-forming cells were visualized and counted by use of an AID ELI-SPOT reader (Autoimmun Diagnostika). The number of spots was standardized to the number spot-forming cells per 6 1 ϫ 10 PBMCs. There was a significant range in the cell viability of the samples, and those with !200 sfc/well in positive control wells were excluded from data analysis. Spots formed in the presence of medium alone were considered to be the result of nonspecific background activity; these were subtracted from the number of spot-forming cells in stimulated wells. There was an overall median response of 27 sfc/ PBMCs in the negative control 6 1 ϫ 10 wells and of 1700 sfc/ PBMCs in positive control wells. 6 1 ϫ 10 A reading of 30 sfc/ PBMCs after the subtraction of non- 6 1 ϫ 10 specific background activity was considered to be positive, as previously defined in pediatric studies, with the same assay, performed by our laboratory [23] . The addition of IL-7 and IL-15 at a concentration of 2.5 ng/mL did not lead to the detection of false-positive spot-forming cells above the positive threshold in control ELISPOT assays performed with PBMCs from HIV-1-seronegative donors. What we term the "total HIV-1-specific response" is the sum of the responses to HIV Gag, Nef, and Tat peptides. A low total response was defined as !300 sfc/ 6 1 ϫ 10 PBMCs, and a high total response was defined as 11000 sfc/ PBMCs. 6 1 ϫ 10 HLA typing. DNA was extracted from PBMCs by use of a QIAamp DNA Mini kit (Qiagen). HLA typing used an amplification refractory mutation system with sequence-specific primers, as described by the manufacturer (Pel-Freeze).
Statistical methods. We used the median and interquartile range as a measurement of the central tendency and variation for continuous variables. We used the Wilcoxon 2-sample test for simple comparison tests and the Spearman rank correlation test for associations between 2 continuous variables. Single and multivariable linear regression modeling was performed by use of Proc Reg in the SAS system. All statistical analyses were performed in the SAS System (version 8.2 for Windows; SAS Institute).
RESULTS

Subject cohort characteristics.
We analyzed peripheral blood samples from 41 children and adolescents with vertically acquired HIV-1 infection; 51% of subjects were Hispanic (n p ), and 49% were African American ( ); 51% were boys 21 n p 20 ( ), and 49% were girls ( ). At the time of study, n p 21 n p 20 their ages ranged from 1.5 to 17.5 years (median, 8.8 years). Viral loads ranged from undetectable levels (!50 HIV-1 RNA copies/mL) to 249,000 HIV-1 RNA copies/mL (median, 29,000 HIV-1 RNA copies/mL), and the CD4 + cell count ranged from 1 to 2136 cells/mL (median, 686 cells/mL) (table 1). Forty children were receiving various treatment regimens, but only 5 reported excellent adherence-the remaining children had variable adherence. Because of variations in treatment regimens and adherence levels, children were not matched for treatment history. One Hispanic child was matched with one African American child on the basis of proximity of age (in months), viral load, and either CD4 + cell count or percentage. In all but 2 pairs, sex was matched as well.
Higher total HIV-specific immune response within age-and disease-matched pairs in African American children. We compared the HIV-specific T cell response to HIV clade B consensus peptide pools of Gag, Nef, and Tat as measured by a cytokineenhanced IFN-g ELISPOT assay between Hispanic and African American children matched for age and disease state. The total HIV-1-specific T cell immune responses of the paired samples are shown in figure 1. In 13 of 18 matched pairs, the African American child showed a higher immune response than the corresponding Hispanic child (figure 1). In Hispanic children, only 5 patients had high total HIV-1-specific responses (11000 sfc/ PBMCs), and the majority of Hispanic children showed 6 1 ϫ 10 low responses (!300 sfc/ PBMCs). 6 1 ϫ 10 Higher total HIV-1-specific immune response in African American children driven by a higher Gag response. When considered as a group, African American children showed a significantly higher total HIV-specific IFN-g response than did Hispanic children ( ) ( figure 2D ). This difference in P p .004 response was driven heavily by the higher Gag-specific response and, to a lesser degree, by the Nef-specific response. Ninety percent of African American children demonstrated a positive Gag-specific response (130 sfc/ PBMCs), as did 70% of 6 1 ϫ 10 Hispanic children. The proportions of positive responders were similar for Nef and were equal for Tat. African American children had a higher magnitude Gag-, Nef-, and Tat-specific T cell response than did Hispanic children, but the difference in only the Gag-specific response was significant ( ) (fig-P p .01 ure 2A-2C). African American children showed an average response of at least 486 sfc/ PBMCs higher than that of 6 1 ϫ 10 Hispanic children ( ) when stimulated with Gag. Al-P p .01 though there was a trend toward a higher Nef response in African American children, overall, the difference was not statistically significant ( ) ( figure 2B ). There were very few P p .06 Tat responders in either group and no significant difference between groups ( ) ( figure 2C ). P p .3 Highest HIV-1-specific immune response in African American girls near the age of puberty among all racial/sex groups. When the children were divided into racial and sex groups, it was clear that the highest Gag-specific and total response was seen in African American girls, with African American boys having the second highest response, Hispanic boys next, and the lowest response in Hispanic girls (figure 3A and 3B). Ninety percent of African American girls, 90% of African American boys, 70% of Hispanic girls, and 63% of Hispanic boys showed a positive Gag-specific response. We concluded that the higher total HIV and Gag-specific responses seen in African American children was significantly driven by the high responses in African American girls. This general pattern held true for Nefand Tat-specific responses as well (data not shown). Although the children were initially matched for viral load, we again verified that there was no significant difference in viral load among the 4 groups that could have led to the observed difference in responses ( figure 3C ).
African American girls enter puberty at an earlier age than do girls of other races; this is estimated to be ∼8.5 years [24] . African American girls showed the highest response of all the ethnic/sex groups, and the highest responders within this category were 6 African American girls clustered near the age of puberty, with a median age of 10.8 years ( figure 4A ).
Relationship between Gag-specific responses and age, CD4 + cell count, or viral load. Interestingly, we observed a nonlinear relationship between Gag-specific responses and each of the parameters we matched for: age, CD4 + cell count, and viral load. Gag-specific responses increased with age until ∼5 years and plateauing until 9 years of age, after which the responses decreased ( figure 4A ). Immune responses increased to a CD4 + cell count of ∼800 cells/mL, after which they declined (figure 4B). With respect to viral load, Gag-specific responses were positive- ly correlated with viral load until 30,000 HIV-1 RNA copies/ mL. Subjects with viral loads 130,000 HIV-1 RNA copies/mL tended to show a decreased immune response ( figure 4C ).
Relative influence of race, sex, age, viral load, and CD4 + cell count on Gag-specific responses. To further delineate the relative influence of ethnicity, sex, age, HIV-1 RNA load, and CD4 + cell count on Gag-specific T cell responses, we performed multivariable linear-regression analyses. To compare groups of patients, we formed sex and ethnic categories, by use of indicator variables, for which African American boys were arbitrarily chosen as the reference group. The multivariable linear-regression analysis demonstrated that, compared with that in African American boys, African American girls had an average response to Gag peptide that was 671.9 sfc/ PBMCs 6 1 ϫ 10 higher ( ). Hispanic girls and boys were estimated to P p .02 have, on average, responses that were 244.6 and 151.2 sfc/1 ϫ 10 6 PBMCs lower than those in African American boys, although these differences were not significant ( and P p .36 , respectively). In this model, neither CD4 + cell count P p .56 (Ϫ0.1 sfc/ PBMCs/CD4 + cell), age in years (Ϫ17.3 sfc/ 6 1 ϫ 10 PBMCs/year older), nor log 10 HIV-1 RNA load (145 6 1 ϫ 10 sfc/ PBMCs/1 log 10 higher HIV-1 RNA) at time of study 6 1 ϫ 10 was associated with an IFN-g response to Gag peptides (P p , , and , respectively). .69 P p .56 P p .11 A*66 and B*58 haplotypes associated with higher Gag-specific response. We then sought to determine the association of HLA class I alleles with the observed IFN-g responses to HIV peptides. HLA typing revealed a wide range of haplotypes (shown in table 1). Of the known HLA class I allele associations, we examined those known to have the strongest association with disease progression on the population level (A*66, B*27, B*35, B*51, B*57, B*58, Cw*02, and Cw*14) [25, 26] , reasoning that these would be the most apparent associations in a small observational cohort study. Of these alleles, we observed 2-A*66 and B*58-to be associated with higher Gag response (P p and , respectively). The 3 subjects with A*66 also .07 P p .007 expressed B*58. The immune responses of the children with the B*58 haplotype are shown in figure 3. There were 7 children with the B*58 haplotype (6 girls). African American girls made up the highest number of children of this haplotype among any ethnic/sex group, with 5 of 10 them carrying the B*58 allele.
DISCUSSION
There is mounting evidence that racial differences in HIV-specific immune responses may exist [2] [3] [4] [5] . To the best of our knowledge, this is the first study to have observed and compared the HIV-specific T cell immune response in vertically infected children of 2 different races who live in geographic proximity. Because age, viral load, and CD4 + cell count are thought to strongly influence the magnitude of the immune response in children [16, 21, 27, 28] , we matched African American and Hispanic children for these 3 parameters, which enabled better direct comparisons between the 2 groups. In our observational cohort of HIV-1-infected children, African American children had a stronger HIV-1-specific T cell immune response than did age-and disease-matched Hispanic children when their PBMCs were stimulated with HIV Gag. Gag was the most frequently recognized antigen, and it led to the highest responses in both groups. Nef responses were the next highest, and there were very few Tat responders in either group. In a linear regression model, when we accounted for viral load, CD4 + cell count, and age, African American girls showed the highest response. In the African American girls, the highest responses were seen in several who were close to the age of puberty. The elevated response in African American girls was a significant factor in the higher response seen in African American children as a whole. We observed a nonlinear relationship between immune response and each of the 3 matched parameters: age, viral load, and CD4 + cell count. We were intrigued by the higher response seen in the African American girls. It is known that HLA class I haplotypes can influence HIV disease progression, with some, such as B*58 and B*27, associated with delayed disease progression, and others, such as B*35, associated with accelerated disease progression [26, 29, 30] . We examined associations between the immune response and HLA haplotypes that are strongly linked to advanced or decreased disease progression, and we found that B*58 was strongly associated with higher Gag-specific IFNg responses. A*66 was also associated with a more-robust immune response. However, the A*66 association appears to be driven by the B*58 effect, given that each A*66 carrier had B*58, but not all B*58 carriers had A*66.
The B*58 haplotype seemed to be present more frequently in the African American girls, with 50% of them in our study carrying the B*58 haplotype. B*58 is mainly found in populations of African descent, at a frequency of ∼6% [31] . The higher frequency of B*58 among African American girls in our cohort suggests a survival advantage mediated by HLA-B*58. B*58 has previously been associated with stronger cytotoxic T lymphocyte immune responses in acute HIV-1 infection [32] . It is possible that HLA-B*58-restricted immune responses target a dominant epitope, leading to a stronger, more effective HIV-specific immune response and slower disease progression. Another alternative is that the B*58 allele is closely linked to another gene that, in turn, mediates the better immune response. One study has shown an association of the CCR2 V64I polymorphism with the B*58 allele in female long-term survivors of HIV infection in Nairobi [33] .
The relationship between the magnitude of the T cell response and plasma viral load is complex, and it often changes with differences in treatment and/or disease level of the subjects studied. Some previous studies found a negative correlation between viral load and Gag-specific proliferative responses and cytokine secretion [34] [35] [36] , whereas more-recent studies have reported no correlation between Gag-specific immune response and viral load [37] [38] [39] . One pediatric study found no correlation between the magnitude or breadth of the HIV-1-specific immune response and viral load [40] . Other investigators have postulated a bell-shaped relationship between Gag-specific T cell responses and viral load [41] . Our results support this and suggest that Gag-specific responses were positively correlated with viral load at lower levels of viremia, when the immune response is driven by antigenic exposure. With higher viremia, the immune response is most likely depleted, inhibited, or overwhelmed, leading to a negative correlation between viral load and immune response.
We observed the highest HIV-1-and Gag-specific responses in African American girls, and they were driven mostly by the high Gag-specific response in a group of girls near the age of puberty (mean age, 10.8 years). It is known that sex-based differences in the immune system exist. Women seem to have more-responsive immune systems, which leads to stronger immune responses but also to higher rates of autoimmune disease [42] [43] [44] . Sex hormones might mediate this difference-estrogens are thought to increase immune function [45, 46] . A possible explanation for the higher responses seen in girls clustered near the age of puberty might be the increase in sex hormones at this age. This could lead to the increased responsiveness of Gag-specific T cells and, hence, the higher response.
Socioeconomic and environmental differences are 2 other possible factors that could lead to the disparate responses observed. However, because all study subjects received care at the same clinic, most lived in geographic proximity and were of a similar socioeconomic level. Cultural differences, such as different dietary practices, including the use of herbal and other nonprescription dietary supplements, could also play a role. Major virological differences are unlikely, given that all of the children were infected with clade B HIV (not shown). Finally, variability in genes controlling immune function might also contribute to variable immune responses. Genes such as those for cytokines, Toll-like receptors, complement proteins, and stress-inducible proteins have shown race-related patterns of genetic polymorphisms [47] [48] [49] [50] [51] [52] [53] .
Although the data presented here suggest a relationship among HIV-specific immune responses, race, and sex, the small number of study participants precluded us from applying these findings to the general population. The interaction between age and puberty as it relates to HIV immune responsiveness remains unclear, but future studies examining longitudinal immune responses may be revealing as these children enter and progress through puberty.
In summary, we have compared the HIV-specific immune response of African American and Hispanic children, and we found that African American children mount a higher HIVspecific immune response than do age-and disease-matched Hispanic children. This difference is driven by the higher Gagspecific response in African American children. African American girls with the HLA class I B*58 allele and who were near the age of puberty showed the highest response, which accounted for most of the higher response seen in African American children as a whole. The observed racial and sex differences in HIV-1-specific T cell immune responses have implications for vaccine development and suggest that monitoring immune responses by both sex and ethnicity worldwide will be of great importance.
